$SRE

Morgan Stanley Adjusts Price Target on Sempra to $104 From $108, Keeps Overweight Rating

Morgan Stanley reduced its price target for Sempra from $108 to $104 but maintained an Overweight rating. Sempra's stock is currently at $87.38, up 1.04% year-to-date. The company recently completed the sale of its Ecogas Mexico natural gas distribution network.

Original reporting
Published Aug 21, 2026, 10:49 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SRE
Neutral
medium confidence
Mentioned
$SRE
Relevance
7/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SRENeutralMed
01

Why it matters

The downgrade reflects a revised view on Sempra's earnings trajectory and valuation multiples.

02

Market read

Analyst price target changes can influence short‑term trading decisions and sentiment for the stock.

03

What to watch

Potential upside from upcoming regulatory approvals and long‑term gas demand trends.

Relevance 7/10Novelty 6/10Timing: pre‑market

Background

Morgan Stanley's research team periodically updates price targets based on valuation and earnings outlook.

Company-level read

Ticker impact

$SRENeutralMedium confidence
Context

Morgan Stanley lowered Sempra's price target to $104 from $108 and kept an overweight rating.

Expected impact

Possible short-term price dip as investors adjust expectations.

Evidence & confidence

Price target adjustments are a direct catalyst but the magnitude is modest; market may react modestly.

Market effects

Utility and energy sector may see slight re‑rating pressure.

U.S. market focus; limited regional spillover.

Low global impact; primarily affects U.S. investors.

Counterpoint

The target cut may be overly cautious if Sempra's recent contract wins sustain earnings growth.

Key entities

  • Morgan Stanley

    Equity research analyst firm providing the price target update.

  • Sempra

    U.S. utility and energy infrastructure company (ticker SRE).

Related articles

$SREMed

Sempra Energy Q2 Earnings Call Highlights

Sempra Energy (SRE) said it expects Texas to exceed 60% of its total rate base by 2030, driven by Oncor. Oncor’s five-year base capital plan totals $47.5B plus $10B incremental opportunities through 2030, tied to ERCOT’s Batch Zero. Sempra also discussed Ecogas sale approval, ECA LNG Phase 1 damage, and leadership changes tied to the SI Partners transaction.

$SREMedAI 8/10

Sempra’s Q2 Earnings Beat Street. The Revenue Miss Didn’t Matter.

Sempra (SRE) reported Q2 2026 adjusted EPS of $1.16, above the $1.06 Street estimate, while revenue fell to $2.997B versus $3.12B expected. Management kept 2026 adjusted EPS guidance at $4.80 to $5.30 and 2027 at $5.10 to $5.70. The article highlights Texas earnings growth and Oncor’s Batch Zero pipeline.

$SREMed

Sempra Q2 GAAP earnings rise to $796 million

Sempra (SRE) reported Q2 2026 GAAP earnings attributable to common shares of $796 million, or $1.21 per diluted share, up from $461 million, or $0.71, a year earlier. Revenues were $2.997 billion. It raised full-year 2026 GAAP EPS guidance to $5.02-$5.55 and affirmed adjusted EPS of $4.80-$5.30. Capex was $2.226 billion; a 45% sale to KKR affiliates is expected to close in Q3 2026.